|
2024
|
Invention
|
Vaccine adjuvant composition and use thereof. The present disclosure provides a vaccine adjuvant ... |
|
|
Invention
|
Hybrid gel comprising particulate decellularized tissue.
A hybrid gel comprising a particulate d... |
|
|
Invention
|
Combination vaccine for prevention of influenza and coronavirus infections. Disclosed is a combin... |
|
|
Invention
|
Combined use of bispecific antibody binding to activated coagulation factor ix and coagulation fa... |
|
|
Invention
|
Tissue fibrosis inhibitor in which biocompatible polymer is used.
A problem to be solved by the ... |
|
2023
|
Invention
|
Diagnostic agent and medicine comprising adamts13 as main ingredient.
New use of ADAMTS13 in the... |
|
|
G/S
|
Vaccines; pharmaceutical preparations. |
|
|
G/S
|
Pharmaceutical preparations; preparations for destroying
vermin; fungicides; herbicides; vaccine... |
|
|
Invention
|
Method for manufacturing inactivated sars-cov-2 vaccine, inactivated sars-cov-2 vaccine, method f... |
|
2022
|
Invention
|
Liquid six combined vaccine composition.
Provided is a liquid formulation of a six combined vacc... |
|
|
Invention
|
Liquid sextuple vaccine composition. The present invention provides a liquefied formulation of a ... |
|
|
Invention
|
Biological tissue adhesive nebulizer and clogging prevention container. A nebulizer capable of re... |
|
|
Invention
|
Modified human serum albumin-thioredoxin fusion body.
Disclosed is a serum albumin-thioredoxin f... |
|
|
Invention
|
Modified human serum albumin-thioredoxin fusion body. Disclosed is a serum albumin-thioredoxin fu... |
|
2021
|
G/S
|
Vaccines for human use |
|
|
G/S
|
Vaccines for human use. |
|
|
Invention
|
Chromatographic method for collecting blood coagulation factor vii with high yield. A chromatogra... |
|
|
Invention
|
Fusion protein of pentamer and gb of cytomegalovirus, and vaccine containing said fusion protein.... |
|
2020
|
Invention
|
Oncolytic vaccinia virus.
Provided is an oncolytic virus having both improved safety and product... |
|
|
Invention
|
Oncolytic vaccinia virus. Provided is an oncolytic virus having both improved safety and producti... |
|
|
Invention
|
Tissue fibrosis inhibitor in which biocompatible polymer is used. A problem to be solved by the p... |
|
|
Invention
|
Porcine circovirus type 2 vlp vaccine. Provided is a PCV2 VLP that can be employed as a vaccine f... |
|
|
Invention
|
Rsv f/g chimeric vaccine. A novel vaccine antigen for prevention of Respiratory Syncytial Virus (... |
|
|
Invention
|
Rsv f/g chimeric vaccine. A novel vaccine antigen for preventing respiratory syncytial virus (RSV... |
|
|
Invention
|
Anti-transthyretin human antibody. A human antibody which comprises a complementarity determining... |
|
|
Invention
|
Method for monomerizing matrix metalloproteinase 7 (mmp-7) aggregate.
A method for monomerizatio... |
|
2019
|
Invention
|
Vaccine for preventing or treating congenital infection with cytomegalovirus.
An object of the p... |
|
|
Invention
|
Vaccine for preventing or treating congenital infection with cytomegalovirus. An object of the pr... |
|
|
Invention
|
Vaccine for preventing or treating congenital infection with cytomegalovirus. The problem address... |
|
|
Invention
|
Anti-igf-i receptor humanized antibody. Provided is a humanized antibody that, through IGF-I rece... |
|
|
Invention
|
Vaccine containing virus-like particles.
The present invention provides a vaccine containing vir... |
|
|
Invention
|
Modified cmv gb protein and cmv vaccine including same.
The present invention is directed to pro... |
|
|
Invention
|
Modified cmv gb protein and cmv vaccine including same. The purpose of the present invention is t... |
|
|
Invention
|
Formed sheet product and hemostatic material. A formed sheet product of a polymer composition com... |
|
|
Invention
|
Modified antibodies with enhanced biological activities.
The present inventors generated modifie... |
|
2018
|
Invention
|
Modified hsv gd protein and vaccine containing same. The modified HSV gD protein of the present i... |
|
|
Invention
|
Modified hsv gb protein and hsv vaccine including same. A modified protein of a herpes simplex vi... |
|
|
Invention
|
Anti-hsv gb monoclonal antibody or antigen-binding fragment thereof. An anti-HSV monoclonal antib... |
|
|
Invention
|
Modified hsv gd protein and vaccine containing same. This modified HSV gD protein is a modified p... |
|
|
Invention
|
Modified hsv gb protein and hsv vaccine including same. Provided is a modified protein of a herpe... |
|
2017
|
Invention
|
Method for producing hib conjugate vaccine using prp with lowered molecular weight. A method for ... |
|
|
Invention
|
Vaccine containing immobilized virus particles. The present invention relates to a vaccine contai... |
|
|
Invention
|
Diagnostic agent and medicine comprising adamts13 as main ingredient. New use of ADAMTS13 in the ... |
|
2015
|
G/S
|
Cell culture-derived Japanese encephalitis vaccines;
pharmaceutical preparations. |
|
2013
|
Invention
|
Human antibody against il-18. The present invention relates to a human anti-human IL-18 antibody ... |
